|Research > MDMA-Assisted Psychotherapy
MDMA-Assisted Psychotherapy for PTSD: Canada
Principal Investigators: Ingrid Pacey, MD and Andrew Feldmár, M.A.
Location: Vancouver, BC (Canada)
This study has full approval from an Institutional Review Board (IRB), Health Canada, and the U.S. FDA. Data will also be submitted under MAPS' U.S. IND #63,384.
Psychiatrist Ingrid Pacey, M.D., a distinguished Holotropic Breathwork facilitator, and psychologist Andrew Feldmar, M.A., are the co-therapists leading the study.
On April 16, 2013, the nine grams of MDMA to be used in the study arrived at the study pharmacy. The study will begin enrollment after an amended protocol receives approval from the IRB.
$584,000 estimated study cost / $568,000 still needed
Please consider donating today to help this study.
Learn more about psychedelic research in Canada at mapscanada.org.
Andrew Feldmár, M.A., Co-therapist
Andrew Feldmár was born in Budapest, Hungary in 1940, and arrived in Canada in 1957. He received is Honours B.A. In Mathematics, Physics, and Chemistry from the Universiy of Toronto in 1962, and his M.A. in Psychology from the University of Western Ontario in 1969. He has been in full-time private practice in psychotherapy since 1975, after a year's apprenticeship with R. D. Laing in London, England. He has been studying entheogens [psychedelics] since 1967. He supervises, teaches, lectures, and publishes both in North America and in Europe.
Video: Andrew Feldmár on MDMA-assisted psychotherapy for PTSD.